Dynatrace target price raised to $71 from $60
DT•Barclays raised its target price for Dynatrace to $71 from $60.
Related News
Moderna schedules third-quarter 2026 financial results call
MRNA•
Opus Genetics presents at Chardan Annual Healthcare Conference
IRD•
United Therapeutics presents preliminary PHINDER study data to develop PH-ILD screening tool at CHEST 2026
UTHR•
Hershey: TD Cowen cuts target price to $198 from $210
HSY•
OMA taps EY as external auditor for fiscal 2026, replacing Deloitte
OMAB•